Medicine & Healthcare Around The World

Amphotericin B: When Medicine Meets Humanity


Listen Later

Timestamps:
0:00 Guest Introduction
7:59 Neglected Global Diseases
21:58 Amphotericin B
35:22 When Medicine Meets Humanity
51:05 The Birth Of NGDI-UBC

Guest Introduction:
Dr. Kishor Wasan's work in pharmaceutical sciences has been recognized with over 25 awards, and he's published more than 550 research papers, focusing on how drugs are delivered in the body. As the former associate dean of Research at the University of British Columbia in Vancouver, Canada and the co-founder of the Neglected Global Disease Initiative at the same university, Dr. Kishor Wasan has dedicated a large part of his life to finding solutions for diseases that often get overlooked. In particular, he's developing an oral, less toxic form of a drug called Amphotericin B, which is currently in clinical trials to treat Leishmaniasis, a neglected tropical disease that devastates many impoverished areas of the world. Let's jump into the episode and hear the story by Dr. Wasan himself.

Watch the video interview on my Youtube channel:
https://youtu.be/ZEO2cyzApGo

Follow Dr. Kishor Wasan:
Linkedin: https://www.linkedin.com/in/dr-kishor-wasan-b6a21728/


Support the work of NGDI-UBC:
Website: https://ngdi.ubc.ca/
X: https://x.com/NGDIUBC1


Follow me on social media: https://beacons.ai/medpathhos


Links & Published Papers :

Leishmaniasis Fact Sheet: World Health Organization Overview

  • Reference: World Health Organization. (n.d.). Leishmaniasis.
  • Link: https://www.who.int/news-room/fact-sheets/detail/leishmaniasis

WHO Meeting Report: PADO for Neglected Tropical Diseases

  • Reference: World Health Organization. (n.d.). WHO GAPF: PADO for Neglected Tropical Diseases Meeting Report.
  • Link: https://cdn.who.int/media/docs/default-source/campaigns-and-initiatives/gap-f/j0155_who-gapf_pado-for-neglected-tropical-diseases-meeting-report_v7.pdf?sfvrsn=7a18cce8_3

Elucidx and UBC Licensing Agreement: Diagnostic Technology Development

  • Reference: Elucidx. (n.d.). Press Release: Elucidx Canada Ltd. and University of British Columbia Finalize Licensing Agreement.
  • Link: https://www.elucidx.ca/post/press-release-elucidx-canada-ltd-and-university-of-british-columbia-finalize-licensing-agreement

The Leishmania donovani Genome Project: Strategies for Comparative Sequencing and Bioinformatics Analysis

  • Reference: Peacock, C. S., Seeger, K., Harris, D., Murphy, L., Ruiz, J. C., Quail, M. A., 1 ... & Blackwell, J. M. (2003). The Leishmania donovani genome project: strategies for comparative sequencing and bioinformatics analysis. BMC bioinformatics, 4(1), 22.   
  • Link: https://pmc.ncbi.nlm.nih.gov/articles/PMC11426499/

Advances in Leishmaniasis Diagnosis and Treatment

  • Reference: Author et al. (2023). Advances in Leishmaniasis Diagnosis and Treatment. PubMed.
  • Link: https://pubmed.ncbi.nlm.nih.gov/37319129/
...more
View all episodesView all episodes
Download on the App Store

Medicine & Healthcare Around The WorldBy Hossam